Table 2.
Comparison of demographics, clinical and laboratory data between the non-PVT group and PVT group in the training set.
| Variable | non-PVT | PVT | P |
|---|---|---|---|
| n = 3,157 | n = 203 | ||
| Age (year) | 55 (47–64) | 56 (50–64) | 0.086 |
| Sex (male/female) | 2,172/985 | 143/60 | 0.624 |
| Smoking history | 261 (8.3%) | 42 (20.7%) | <0.001 |
| Cause of admission | 0.003 | ||
| Gastrointestinal bleeding | 401 (12.7%) | 43 (21.2%) | |
| Ascites | 628 (19.9%) | 43 (21.2%) | |
| Jaundice | 272 (8.6%) | 11 (5.4%) | |
| Dysfunction of liver | 171 (5.4%) | 8 (3.9%) | |
| Infection | 781 (24.7%) | 53 (26.1%) | |
| Abdominal discomfort | 715 (22.6%) | 30 (14.8%) | |
| Other | 189 (6.0%) | 15 (7.4%) | |
| Etiology | 0.763 | ||
| Hepatitis | 1,965 (62.2%) | 131 (64.5%) | |
| Alcoholic | 673 (21.3%) | 44 (21.7%) | |
| Autoimmune | 91 (2.9%) | 4 (2.0%) | |
| Other | 428 (13.6%) | 24 (11.8%) | |
| Complications | |||
| Splenomegaly | 2,012 (63.7%) | 165 (81.3%) | <0.001 |
| Portal_hypertension | 1,281 (40.6%) | 129 (63.5%) | <0.001 |
| Esophagogastric varices | 1,023 (32.4%) | 116 (57.1%) | <0.001 |
| Gastrointestinal_bleeding | 449 (14.2%) | 47 (23.2%) | 0.001 |
| Ascites | 1,081 (34.2%) | 79 (38.9%) | 0.174 |
| Encephalopathy | 163 (5.2%) | 17 (8.4%) | 0.049 |
| Comorbidities | |||
| Hypertension | 504 (16.0%) | 29 (14.3%) | 0.526 |
| Diabetes | 469 (14.9%) | 40 (19.7%) | 0.062 |
| Heart disease | 173 (5.5%) | 9 (4.4%) | 0.523 |
| Renal failure | 21 (0.7%) | 1 (0.5%) | 0.768 |
| Surgical history | 307 (9.7%) | 46 (22.7%) | <0.001 |
| Sepsis | 59 (1.9%) | 2 (1.0%) | 0.361 |
| Child-pugh classification | 0.416 | ||
| A | 1,088 (34.5%) | 61 (30.0%) | |
| B | 1,402 (44.4%) | 98 (48.3%) | |
| C | 667 (21.1%) | 44 (21.7%) | |
| RBC transfusion | 264 (8.4%) | 38 (18.7%) | <0.001 |
| WBC (× 109/L) | 4.91 (3.47–6.88) | 4.38 (3.09–6.50) | 0.040 |
| Hb (g/L) | 111 (90–127) | 100 (80–116) | <0.001 |
| HCT (%) | 33.3 (27.6–38.3) | 31.1 (25.3–35.1) | <0.001 |
| PLT (× 109/L) | 97 (60–151) | 91 (49–145) | 0.114 |
| PT (s) | 13.5 (11.9–16.0) | 13.9 (12.3–16.6) | 0.044 |
| INR | 1.18 (1.04–1.38) | 1.21 (1.08–1.44) | 0.036 |
| APTT (s) | 38.0 (31.4–47.3) | 39.1 (31.0–49.3) | 0.473 |
| DDi (mg/L) | 1.03 (0.40–2.77) | 1.76 (0.54–4.73) | <0.001 |
| TB (μmol/L) | 27.7 (16.7–58.5) | 27.4 (16.9–46.4) | 0.645 |
| ALB (g/L) | 31.5 (27.4–35.8) | 29.6 (25.9–34.6) | 0.003 |
| ALT (U/L) | 43.1 (24.1–91.4) | 29.5 (19.1–52.3) | <0.001 |
| AST (U/L) | 61.0 (34.6–117.5) | 42.6 (28.9–82.4) | <0.001 |
RBC transfusion, red blood cell transfusion; WBC, white blood cell count; Hb, hemoglobin; Hct, Hematokrit; PT, prothrombin time; APTT, activated partial thromboplastin time; INR, international normalized ratio; DDi, D-dimer; TB, total bilirubin; ALB, albumin; ALT, alanine transaminase; AST, aspartate aminotransferase.